Serum lipoprotein (a)in hospitalized patients with type 2 diabetes mellitus and its association with diabetic nephropathy

Jie-min PAN,Yu-qian BAO,Lei ZHANG,Yang ZHANG,Hao-yong YU,Wei-ping JIA

DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2009.03.009

2009-01-01

Abstract:Objective To evaluate the correlation of serum lipoprotein (a) (Lp (a)) with diabetic nephropathy in hospitalized type 2 diabetes mellitus. Methods Lipid profile, blood glucose, serum creatinine and urinary albumin excretion rate (UAER) were measured in 1238 hospitalized type 2 diabetic patients from January 2007 to November 2008. The blood pressure, body weight and diabetes duration were recorded. Glomerular filtration rate (GFR) was estimated by the simplified MDRD equation, t test and multiple stepwise regression were used for data analysis. Results There was no significant difference in serum Lp (a) level among different age group (F = 1.144, P > 0.05). Serum Lp (a) level of macroalbuminuria group was significantly higher than that of nomoalbuminuria or microalbuminuria group (F = 4.113, P < 0.05). The cohort was divided into four groups by the quartile of serum Lp(a). It was demonstrated that UAER was increased with serum Lp(a) level while GFR decreased (F =7.877 or 4.479, P <0.01). Lp(a) showed positive correlations with total cholesterol, low-density lipoprotein cholesterol (LDL-C) and UAER (r =0.152, 0.169, and 0.18, P < 0.01) and a negative correlation with GFR (r = - 0.061, P < 0.01). Systolic pressure, Lp (a), LDL-C, GFR, and age were independent risk factors for UAER according to multiple stepwise regression analysis. Conclusions Serum Lp(a) level might be associated with the onset and progression of diabetic nephropathy regardless of age, diabetic duration and glycemic control.